News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<IPO>A.S. Watson Said to Advance USD2B Dual Listing in HK, London by End-2026
A.S. Watson Group, a subsidiary of CKH HOLDINGS (00001.HK), may proceed with a dual listing in Hong Kong and London by the end of 2026, aiming to raise about USD2 billion, Financia...
Reset
Send
The window will close in 5 seconds
<IPO>A.S. Watson Said to Advance USD2B Dual Listing in HK, London by End-2026
Close
Recommend
31
Positive
46
Negative
17
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

A.S. Watson Group, a subsidiary of CKH HOLDINGS (00001.HK)  +1.300 (+1.880%)    Short selling $168.09M; Ratio 15.109%   , may proceed with a dual listing in Hong Kong and London by the end of 2026, aiming to raise about USD2 billion, Financial Times reported, quoting people with the knowledge of the matter. The group is valued at USD30 billion.

A.S. Watson has been working with Goldman Sachs, UBS and Latham & Watkins on the IPO, and has not yet selected its primary listing destination, sources divulged.

Related News CLSA Upgrades CKH HOLDINGS (00001.HK) to "High-Conviction Outperform", Raises TP to HKD102
Malina Ngai, CEO of A.S. Watson, did not directly respond to the potential IPO plan, while accentuating that the group's business model balances stability and flexibility amid geopolitical uncertainties.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-29 16:25.)

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.